Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,384 | -37,065 | -23,418 | -10,257 | -41,360 |
| Depreciation Amortization | 254 | 177 | 136 | 80 | 219 |
| Accounts payable and accrued liabilities | 389 | 505 | 655 | 1,030 | 313 |
| Other Working Capital | 514 | -265 | -1,967 | -3,790 | 1,512 |
| Other Operating Activity | 3,456 | 2,362 | 1,209 | -83 | 1,918 |
| Operating Cash Flow | $-46,771 | $-34,286 | $-23,385 | $-13,020 | $-37,398 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,620 | 12,871 | 21,703 | 18,315 | -16,703 |
| PPE Investments | -12 | -12 | -12 | -12 | -18 |
| Investing Cash Flow | $-1,632 | $12,859 | $21,691 | $18,303 | $-16,721 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 47,000 | 47,000 | N/A | N/A | N/A |
| Common Stock Issued | 860 | 860 | 715 | 472 | 81,449 |
| Other Financing Activity | 1,241 | 1,251 | 1,405 | -12 | 15,432 |
| Financing Cash Flow | $49,101 | $49,111 | $2,120 | $460 | $96,881 |
| Beginning Cash Position | 47,786 | 47,786 | 47,786 | 47,786 | 5,024 |
| End Cash Position | 48,484 | 75,470 | 48,212 | 53,529 | 47,786 |
| Net Cash Flow | $698 | $27,684 | $426 | $5,743 | $42,762 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,771 | -34,286 | -23,385 | -13,020 | -37,398 |
| Capital Expenditure | -12 | -12 | -12 | -12 | -18 |
| Free Cash Flow | -46,783 | -34,298 | -23,397 | -13,032 | -37,416 |